136 related articles for article (PubMed ID: 1661736)
1. Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.
Berns A
J Cell Biochem; 1991 Oct; 47(2):130-5. PubMed ID: 1661736
[TBL] [Abstract][Full Text] [Related]
2. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
3. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
[TBL] [Abstract][Full Text] [Related]
4. Oncogenesis by Moloney murine leukemia virus.
Tsichlis PN
Anticancer Res; 1987; 7(2):171-80. PubMed ID: 3592629
[TBL] [Abstract][Full Text] [Related]
5. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
Nature; 1989 Jul; 340(6228):61-3. PubMed ID: 2786994
[TBL] [Abstract][Full Text] [Related]
6. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
7. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
8. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
9. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
10. Using retroviruses as insertional mutagens to identify cellular oncogenes.
Varmus HE
Prog Clin Biol Res; 1983; 119():23-35. PubMed ID: 6867028
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
12. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.
Rasmussen MH; Sørensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS
Virology; 2005 Jul; 337(2):353-64. PubMed ID: 15913695
[TBL] [Abstract][Full Text] [Related]
13. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
14. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
Dupressoir A; Heidmann T
Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
[TBL] [Abstract][Full Text] [Related]
15. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
17. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
18. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
Alexander WS; Bernard O; Cory S; Adams JM
Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
[TBL] [Abstract][Full Text] [Related]
19. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of collaborating oncogenes in compound mutant mice.
Berns A; Mikkers H; Krimpenfort P; Allen J; Scheijen B; Jonkers J
Cancer Res; 1999 Apr; 59(7 Suppl):1773s-1777s. PubMed ID: 10197595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
